Alantolactone
Based on 10 publication(s) in Google Scholar
Alantolactone is a selective STAT3 inhibitor, with potent anticancer activity. Alantolactone induces apoptosis in cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.94%
- CAS No.: 546-43-0
- 화학식: C15H20O2
- 분자량:232.32
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Alantolactone
More- EBioMedicine. 2022 Nov:85:104274. [Abstract]
- Pharmacol Res. 2020 May;155:104751. [Abstract]
- Phytomedicine. 2024 Jan:122:155159. [Abstract]
- ACS Appl Mater Interfaces. 2025 Oct 8;17(40):55848-55860. [Abstract]
- Cancer Cell Int. 2020 Sep 9;20:442. [Abstract]
- Front Pharmacol. 2021 Sep 28:12:730312. [Abstract]
- Stem Cells. 2019 Feb;37(2):190-201. [Abstract]
- Mamm Genome. 2025 Dec 23;37(1):20. [Abstract]
- Biol Pharm Bull. 2024;47(7):1255-1264. [Abstract]
- bioRxiv. 2025 May 4:2025.04.29.651320. [Abstract]
-
WB
-
WB
Biological Activity
|
STAT3 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
0.55 μg/mL
Compound: 6
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
|
[PMID: 23451797] |
| HepG2 | IC50 |
1.3 μg/mL
Compound: 6
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
|
[PMID: 23451797] |
| HT-1080 | IC50 |
0.696 μg/mL
Compound: 6
|
Antiproliferative activity against human HT1080 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
Antiproliferative activity against human HT1080 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
|
[PMID: 23451797] |
| HUVEC | IC50 |
2.4 μg/mL
Compound: 6
|
Antiproliferative activity against human HUVEC assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
Antiproliferative activity against human HUVEC assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay
|
[PMID: 23451797] |
| K562 | IC50 |
0.7 μM
Compound: 1
|
In vitro inhibitory activity against K562 human leukemia cell line
In vitro inhibitory activity against K562 human leukemia cell line
|
[PMID: 11212128] |
| K562 | IC50 |
0.7 μM
Compound: 20
|
Antiproliferative activity against human K562 cells
Antiproliferative activity against human K562 cells
|
10.1039/C2MD20172K |
| MDA-MB-231 | IC50 |
15 μM
Compound: 23
|
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 33650861] |
| RAW264.7 | IC50 |
1.17 μM
Compound: 29
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins before LPS challenge measured 24 hrs after LPS challenge by Griess reaction method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins before LPS challenge measured 24 hrs after LPS challenge by Griess reaction method
|
[PMID: 21924800] |
Alantolactone induces apoptosis in HepG2 cells in a dose-dependent manner. This Alantolactone-induced apoptosis is found to be associated with GSH depletion, inhibition of STAT3 activation, ROS generation, mitochondrial transmembrane potential dissipation, and increased Bax/Bcl-2 ratio and caspase-3 activation[1]. Alantolactone decreases STAT3 translocation to the nucleus, its DNA-binding, and STAT3 target gene expression. Alantolactone significantly inhibits STAT3 activation with a marginal effect on MAPKs and on NF-κB transcription; however, this effect is not mediated by inhibiting STAT3 upstream kinases[2].
?
Alantolactone induces activin/SMAD3 signaling in human colon adenocarcinoma HCT-8 cells. Alantolactone performs its antitumor effect by interrupting the interaction between Cripto-1 and the activin receptor type IIA in the activin signaling pathway[4].
?
Alantolactone (5 μg/mL, 24 h) inhibits cell proliferation in colon adenocarcinoma HCT-8 cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT-8 cells.
-
Concentration:5 μg/mL (~21.6 μM).
-
Incubation Time:24 h.
-
Result:Activated the activin signaling pathway in HCT-8 cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female athymic BALB/c nude mice at the age of 6 weeks[2].
-
Dosage:2.5 mg/kg.
-
Administration:I.P. injection every 2 days.
-
Result:Exhibited anti-cancer activity.
Chemical Information
-
CAS No. 546-43-0
-
Appearance Solid
-
분자량 232.32
-
화학식 C15H20O2
-
Color White to off-white
-
SMILES
O=C(O[C@@]1([H])[C@]2([H])C=C3[C@@H](C)CCC[C@]3(C)C1)C2=C
-
Synonyms
(+)-Alantolactone; Alant camphor; Inula camphor
-
Structure Classification
-
Initial Source
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (10)
-
Journal Impact Factor
-
Most Recent
-
EBioMedicine
2022 Nov:85:104274. PMID: 36182775 -
Pharmacol Res
Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis. [Abstract]2020 May;155:104751. PMID: 32151678 -
Phytomedicine
Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases. [Abstract]2024 Jan:122:155159. PMID: 37931457 -
ACS Appl Mater Interfaces
Synchronous Sterilization and Macrophage Regulation for Treating Multidrug-Resistant Pseudomonas aeruginosa-Infected Pneumonia. [Abstract]2025 Oct 8;17(40):55848-55860. PMID: 40987591 -
Cancer Cell Int
Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia. [Abstract]2020 Sep 9;20:442. PMID: 32943990 -
Front Pharmacol
Selective STAT3 Inhibitor Alantolactone Ameliorates Osteoarthritis via Regulating Chondrocyte Autophagy and Cartilage Homeostasis. [Abstract]2021 Sep 28:12:730312. PMID: 34650433 -
Stem Cells
Glycoprotein M6B Interacts with TβRI to Activate TGF-β-Smad2/3 Signaling and Promote Smooth Muscle Cell Differentiation. [Abstract]2019 Feb;37(2):190-201. PMID: 30372567
Alantolactone purchased from MedChemExpress. Usage Cited in: Stem Cells. 2019 Feb;37(2):190-201. [Abstract]
Western blot images show Smad2/3 phosphorylation is lower than baseline in the sh-GPM6B cells and higher than baseline in the GPM6B-sgRNA cells. The phosphorylation of Smad2/3 in the sh-GPM6B TGF-β1 group is elevated by Alantolactone and the phosphorylation is reduced by treatment with SB431542.
Alantolactone purchased from MedChemExpress. Usage Cited in: Stem Cells. 2019 Feb;37(2):190-201. [Abstract]
Western blot analyses show the repression of SMC specific markers in the sh-GPM6B TGF-β1 group are abolished by Alantolactone in the sh-GPM6B and the enrichment of SMC specific markers in the GPM6B-sgRNA cells is cancelled by treatment with SB431542.
-
Mamm Genome
Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis. [Abstract]2025 Dec 23;37(1):20. PMID: 41436627 -
Biol Pharm Bull
Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway. [Abstract]2024;47(7):1255-1264. PMID: 38972750 -
bioRxiv
2025 May 4:2025.04.29.651320. PMID: 40654780
용액&용해도
DMSO : 100 mg/mL (430.44 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (10.76 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (10.76 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (281 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Khan M, et al. Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction. Biomed Res Int. 2013;2013:719858. [Content Brief]
[2]. Chun J, et al. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells. Cancer Lett. 2015 Feb 1;357(1):393-403. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.3044 mL | 21.5220 mL | 43.0441 mL | 107.6102 mL |
| 5 mM | 0.8609 mL | 4.3044 mL | 8.6088 mL | 21.5220 mL | |
| 10 mM | 0.4304 mL | 2.1522 mL | 4.3044 mL | 10.7610 mL | |
| 15 mM | 0.2870 mL | 1.4348 mL | 2.8696 mL | 7.1740 mL | |
| 20 mM | 0.2152 mL | 1.0761 mL | 2.1522 mL | 5.3805 mL | |
| 25 mM | 0.1722 mL | 0.8609 mL | 1.7218 mL | 4.3044 mL | |
| 30 mM | 0.1435 mL | 0.7174 mL | 1.4348 mL | 3.5870 mL | |
| 40 mM | 0.1076 mL | 0.5381 mL | 1.0761 mL | 2.6903 mL | |
| 50 mM | 0.0861 mL | 0.4304 mL | 0.8609 mL | 2.1522 mL | |
| 60 mM | 0.0717 mL | 0.3587 mL | 0.7174 mL | 1.7935 mL | |
| 80 mM | 0.0538 mL | 0.2690 mL | 0.5381 mL | 1.3451 mL | |
| 100 mM | 0.0430 mL | 0.2152 mL | 0.4304 mL | 1.0761 mL |